Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial

Mirja Puolakkainen1, Cho-Chou Kuo, Lee Ann Campbell

  • 1Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195, USA.

Insights

Chlamydia pneumoniae uses the mannose 6-phosphate/IGF2 receptor for attachment and entry into endothelial cells, unlike Chlamydia trachomatis. This receptor usage differs significantly between these two Chlamydia species.

Area of Science:

  • Microbiology
  • Cell Biology
  • Infectious Diseases

Background:

  • Chlamydia species exhibit varied mechanisms for host cell attachment and entry.
  • Previous work identified a high-mannose oligosaccharide on Chlamydia trachomatis outer membrane protein, inhibiting its infectivity.
  • Insulin-like growth factor 2 (IGF2) enhances Chlamydia pneumoniae, but not Chlamydia trachomatis, infectivity in endothelial cells.

Purpose of the Study:

  • To investigate the role of the mannose 6-phosphate (M6P)/IGF2 receptor in the infection of human microvascular endothelial cells (HMEC-1) by Chlamydia species.
  • To determine if Chlamydia pneumoniae utilizes the M6P/IGF2 receptor for cellular entry.
  • To compare the receptor usage for attachment and entry between Chlamydia pneumoniae and Chlamydia trachomatis.

Main Methods:

  • Hapten inhibition assays were performed using M6P and M6P-poly[N-(2-hydroxyethyl)-acrylamide] (M6P-PAA) to block receptor binding.
  • Mannan was used as a control inhibitor.
  • Metabolically labeled Chlamydia organisms were incubated with endothelial cells at 4°C (attachment) and 37°C (internalization) to assess attachment and entry inhibition.

Main Results:

  • M6P and M6P-PAA inhibited the infectivity of Chlamydia pneumoniae but not Chlamydia trachomatis serovars UW5 or L2.
  • Mannan inhibited Chlamydia trachomatis but not Chlamydia pneumoniae.
  • M6P-PAA significantly inhibited both the attachment and internalization of Chlamydia pneumoniae in endothelial cells, while having no effect on Chlamydia trachomatis serovars E or L2.

Conclusions:

  • Chlamydia pneumoniae employs the M6P/IGF2 receptor for attachment and entry into endothelial cells.
  • The mechanisms of attachment and entry, specifically the utilization of the M6P/IGF2 receptor, are distinct between Chlamydia pneumoniae and Chlamydia trachomatis.
  • These findings highlight species-specific differences in Chlamydia-host cell interactions.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
689
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K